These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24767765)

  • 21. Women are from SATURN and men are from an ASTEROID: deciphering the REVERSAL of coronary atheroma.
    Garcia-Garcia HM; Campos CM; Serruys PW
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):1023-4. PubMed ID: 25323164
    [No Abstract]   [Full Text] [Related]  

  • 22. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy.
    Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Nov; 34(41):3182-90. PubMed ID: 23886915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.
    Gao Y; Jia ZM; Sun YJ; Zhang ZH; Ren LN; Qi GX
    Chin Med J (Engl); 2012 Jul; 125(13):2250-4. PubMed ID: 22882843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose statins should be used in all patients undergoing percutaneous coronary intervention.
    Cay S; Durmaz T; Canpolat U; Aydogdu S
    Int J Cardiol; 2013 Oct; 168(5):5103-4. PubMed ID: 23962786
    [No Abstract]   [Full Text] [Related]  

  • 26. Statins for the prevention of contrast-induced acute kidney injury.
    Ball T; McCullough PA
    Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes.
    Wang Z; Dai H; Xing M; Yu Z; Lin X; Wang S; Zhang J; Hou F; Ma Y; Ren Y; Tan K; Wang Y; Ge Z
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):327-33. PubMed ID: 23364255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER).
    Nicholls SJ; Brandrup-Wognsen G; Palmer M; Barter PJ
    Am J Cardiol; 2010 Jan; 105(1):69-76. PubMed ID: 20102893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
    Han Y; Zhu G; Han L; Hou F; Huang W; Liu H; Gan J; Jiang T; Li X; Wang W; Ding S; Jia S; Shen W; Wang D; Sun L; Qiu J; Wang X; Li Y; Deng J; Li J; Xu K; Xu B; Mehran R; Huo Y
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):62-70. PubMed ID: 24076297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dyslipidaemia: Promising results for TA-8995 in TULIP.
    Mearns BM
    Nat Rev Cardiol; 2015 Aug; 12(8):443. PubMed ID: 26099844
    [No Abstract]   [Full Text] [Related]  

  • 31. The evolving role of CETP inhibition: beyond HDL cholesterol.
    Ray KK; Vallejo-Vaz AJ
    Lancet; 2015 Aug; 386(9992):412-4. PubMed ID: 26047976
    [No Abstract]   [Full Text] [Related]  

  • 32. Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: an analysis from the VOYAGER database.
    Palmer MK; Nicholls SJ; Lundman P; Barter PJ; Karlson BW
    Eur J Prev Cardiol; 2013 Dec; 20(6):1080-7. PubMed ID: 23644489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
    Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
    Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.
    Yun KH; Jeong MH; Oh SK; Rhee SJ; Park EM; Lee EM; Yoo NJ; Kim NH; Ahn YK; Jeong JW
    Int J Cardiol; 2009 Nov; 137(3):246-51. PubMed ID: 18706705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACP Journal Club. Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non-ST-elevation ACS.
    Molnar AO; Garg AX
    Ann Intern Med; 2014 May; 160(10):JC9. PubMed ID: 24842443
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes.
    Marenzi G; Cosentino N; Werba JP; Tedesco CC; Veglia F; Bartorelli AL
    Int J Cardiol; 2015 Mar; 183():47-53. PubMed ID: 25662053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of early intensive rosuvastatin therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (ROSEMARY Study).
    Ko YG; Won H; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Bae JH; Lee S; Lim DS; Jang Y
    Am J Cardiol; 2014 Jul; 114(1):29-35. PubMed ID: 24831577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high].
    MMW Fortschr Med; 2001 Nov; 143(44):60. PubMed ID: 11732408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.